Cancer Science & Therapy

Gary Guishan Xiao

Gary Guishan Xiao, PhD
Director
Creighton University, Genomics and Functional Proteomics Laboratories, USA

Biography

Gary Guishan Xiao is a Director of the Functional Genomics and Proteomics laboratories at the Creighton University. Osteoporosis Research Center, is an internationally recognized expert in the field of proteomics and metabolomics of cancers and bone disease. Dr. Xiao earns his Ph.D. in molecular computational biology about a dozen years ago, focusing on structural modeling of ligand-enzyme interaction and prediction of protein refolding pathways during protein translational process. Dr. Xiao had his postdoctoral research trained in Baylor College of Medicine and UCLA, focusing on pharmacokinetics and biochemistry of non-steroid inflammatory drugs such as aspirin-derivatives and their target, human prostaglandin H synthases H1 and H2, and cell cycle regulation, especially, the role of c-Myc in cardiac termination differentiation. Dr. Xiao’s research at harbor UCLA medical Center and City of Hope National Cancer Center were highly focused on genomic and proteomic interpretations of diet-induced obesity/diabetes and its complications such cancers and osteoporosis. Dr. Xiao joined Osteoporosis Research Center at the Creighton University Medical Center since 2007. Dr. Xiao has been regular reviewer or ad hoc reviewer for several medial journals, different funding agency such as NIH and several journal Editorial Board members.

Research Interest

Functional genomics & proteomics analyses of complex disease Including osteoporosis and cancer (especially, breast cancer, pancreatic cancer and prostate cancer). Function of microRNA in estrogen signaling, functional proteomics (focusing on the role of protein posttranslational modifications in cancer and osteoporosis), and proteomics technology development.